Type

Range

Units

Status

Start Date

End Date

Financing

Study Design

Brief description/objective

The aim of this registry is to prolong the patient observation
period and recruit new patients to gain further insights into the
long-term use of NOACs, including switching from Vitamin K
antagonists (VKAs), to NOACs in a real life setting. This will
include the collection of data on direct healthcare resource use
and estimated costs correlated in patients with AF.
Primary Objective: To describe the long-term use of NOACs and
corresponding prescription patterns, including reasons for
switching from VKAs to NOACs.